<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_transfusion" title="Influence of Transfusion on the Risk of Acute Kidney Injury: ABO-Compatible versus ABO-Incompatible Liver Transplantation" shortTitle="transfusion" author="Je  Hyuk Yu, Yongsuk Kwon, Jay Kim, Seong-Mi Yang, Won  Ho Kim, Chul-Woo Jung, Kyung-Suk Suh, Kook  Hyun Lee" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2077-0383/8/11/1785/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
4.	LS	4.
Discussion	NN	discussion
</s>
</head>
<p>
<s type="decl">
The	DT	the
main	JJ	main
finding	NN	finding
of	IN	of
our	PRP$	our
study	NN	study
is	VBZ	be
that	IN	that
the	DT	the
risk	NN	risk
of	IN	of
AKI	NNP	AKI
rose	VBD	rise
proportionally	RB	proportionally
according	VBG	accord
to	IN	to
the	DT	the
amount	NN	amount
of	IN	of
pRBC	NN	pRBC
and	CC	and
FFP	NNP	FFP
transfusions	NNS	transfusion
in	IN	in
both	CC	both
ABO-c	NNP	ABO-c
and	CC	and
ABO-i	NNP	ABO-i
LT	NNP	LT
,	,	,
but	CC	but
this	DT	this
association	NN	association
of	IN	of
pRBC	NN	pRBC
and	CC	and
FFP	NNP	FFP
transfusions	NNS	transfusion
with	IN	with
post-transplant	JJ	post-transplant
AKI	NNP	AKI
was	VBD	be
stronger	JJR	strong
in	IN	in
ABO-i	NNP	ABO-i
LT	NNP	LT
than	IN	than
in	IN	in
ABO-c	NNP	ABO-c
LT	NNP	LT
.	.	.
</s>
<s type="decl">
Given	VBN	give
that	IN	that
the	DT	the
AKI	NNP	AKI
rates	NNS	rate
increased	VBD	increase
in	IN	in
patients	NNS	patient
with	IN	with
preoperative	JJ	preoperative
anemia	NN	anemia
and	CC	and
that	IN	that
the	DT	the
influence	NN	influence
of	IN	of
transfusion	NN	transfusion
on	IN	on
AKI	NNP	AKI
was	VBD	be
more	RBR	more
pronounced	VBN	pronounce
in	IN	in
ABO-i	NNP	ABO-i
LT	NNP	LT
patients	NNS	patient
,	,	,
any	DT	any
efforts	NNS	effort
to	TO	to
reduce	VB	reduce
perioperative	JJ	perioperative
transfusions	NNS	transfusion
may	MD	may
protect	VB	protect
patients	NNS	patient
with	IN	with
ABO-i	NNP	ABO-i
LT	NNP	LT
against	IN	against
AKI	NNP	AKI
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
as	IN	as
our	PRP$	our
observations	NNS	observation
were	VBD	be
from	IN	from
a	DT	a
retrospective	JJ	retrospective
analysis	NN	analysis
,	,	,
prospective	JJ	prospective
trials	NNS	trial
are	VBP	be
required	VBN	require
to	TO	to
confirm	VB	confirm
our	PRP$	our
hypothesis	NN	hypothesis
.	.	.
</s>
</p>
<p>
<s type="decl">
Patient	NN	patient
mortality	NN	mortality
and	CC	and
graft	NN	graft
survival	NN	survival
after	IN	after
ABO-i	NNP	ABO-i
LT	NNP	LT
have	VBP	have
been	VBN	be
reported	VBN	report
to	TO	to
be	VB	be
comparable	JJ	comparable
to	IN	to
ABO-c	NNP	ABO-c
LT	NNP	LT
,	,	,
although	IN	although
there	EX	there
is	VBZ	be
still	RB	still
concern	NN	concern
regarding	VBG	regard
the	DT	the
high	JJ	high
incidence	NN	incidence
of	IN	of
antibody-mediated	JJ	antibody-mediated
rejection	NN	rejection
,	,	,
including	VBG	include
biliary	JJ	biliary
stricture	NN	stricture
related	VBN	relate
to	IN	to
a	DT	a
high	JJ	high
isoagglutinin	NN	isoagglutinin
titer	NN	titer
.	.	.
</s>
<s type="decl">
This	DT	this
high	JJ	high
isoagglutinin	NN	isoagglutinin
titer	NN	titer
may	MD	may
provoke	VB	provoke
another	DT	another
major	JJ	major
organ	NN	organ
injury	NN	injury
,	,	,
including	VBG	include
AKI	NNP	AKI
,	,	,
through	IN	through
an	DT	a
immunologic	JJ	immunologic
response	NN	response
.	.	.
</s>
<s type="decl">
As	IN	as
AKI	NNP	AKI
affects	VBZ	affect
graft	NN	graft
outcomes	NNS	outcome
and	CC	and
mortality	NN	mortality
after	IN	after
liver	NN	liver
transplantation	NN	transplantation
,	,	,
it	PRP	it
is	VBZ	be
important	JJ	important
to	TO	to
elucidate	VB	elucidate
modifiable	JJ	modifiable
risk	NN	risk
factors	NNS	factor
of	IN	of
AKI	NNP	AKI
in	IN	in
ABO-i	NNP	ABO-i
LT	NNP	LT
.	.	.
</s>
</p>
<p>
<s type="decl">
The	DT	the
reason	NN	reason
why	WRB	why
AKI	NNP	AKI
occurs	VBZ	occur
more	RBR	more
frequently	RB	frequently
in	IN	in
ABO-i	NNP	ABO-i
LT	NNP	LT
is	VBZ	be
not	RB	not
certain	JJ	certain
,	,	,
although	IN	although
the	DT	the
high	JJ	high
isoagglutinin	NN	isoagglutinin
titer	NN	titer
may	MD	may
play	VB	play
a	DT	a
role	NN	role
.	.	.
</s>
<s type="decl">
A	DT	a
high	JJ	high
isoagglutinin	NN	isoagglutinin
titer	NN	titer
may	MD	may
lead	VB	lead
to	IN	to
major	JJ	major
organ	NN	organ
damage	NN	damage
through	IN	through
possible	JJ	possible
immunologic	JJ	immunologic
injury	NN	injury
.	.	.
</s>
<s type="sub">
In	IN	in
addition	NN	addition
,	,	,
the	DT	the
prevalent	JJ	prevalent
baseline	NN	baseline
metabolic	JJ	metabolic
alkalosis	NN	alkalosis
,	,	,
low	JJ	low
platelet	NN	platelet
count	NN	count
,	,	,
and	CC	and
high	JJ	high
incidence	NN	incidence
of	IN	of
mild	JJ	mild
arterial	JJ	arterial
hypoxemia	NN	hypoxemia
prior	RB	prior
to	IN	to
transplantation	NN	transplantation
surgery	NN	surgery
may	MD	may
contribute	VB	contribute
to	IN	to
the	DT	the
high	JJ	high
incidence	NN	incidence
of	IN	of
intraoperative	JJ	intraoperative
transfusion	NN	transfusion
and	CC	and
low	JJ	low
oxygen	NN	oxygen
delivery	NN	delivery
to	IN	to
the	DT	the
kidney	NN	kidney
.	.	.
</s>
<s type="decl">
Furthermore	RB	furthermore
,	,	,
patients	NNS	patient
with	IN	with
ABO-i	NNP	ABO-i
LT	NNP	LT
already	RB	already
receive	VBP	receive
a	DT	a
substantial	JJ	substantial
amount	NN	amount
of	IN	of
FFP	NNP	FFP
transfusion	NN	transfusion
for	IN	for
plasma	NN	plasma
exchange	NN	exchange
prior	RB	prior
to	IN	to
surgery	NN	surgery
.	.	.
</s>
<s type="decl">
FFP	NNP	FFP
has	VBZ	have
been	VBN	be
reported	VBN	report
to	TO	to
be	VB	be
a	DT	a
risk	NN	risk
factor	NN	factor
for	IN	for
AKI	NNP	AKI
after	IN	after
surgery	NN	surgery
,	,	,
including	VBG	include
liver	NN	liver
transplantation	NN	transplantation
,	,	,
and	CC	and
the	DT	the
risk	NN	risk
of	IN	of
AKI	NNP	AKI
may	MD	may
increase	VB	increase
when	WRB	when
patients	NNS	patient
with	IN	with
ABO-i	NNP	ABO-i
LT	NNP	LT
receive	VBP	receive
intraoperative	JJ	intraoperative
FFP	NNP	FFP
transfusions	NNS	transfusion
.	.	.
</s>
<s type="sub">
Furthermore	RB	furthermore
,	,	,
an	DT	a
inflammatory	JJ	inflammatory
,	,	,
allergic	JJ	allergic
,	,	,
and	CC	and
immunologic	JJ	immunologic
reaction	NN	reaction
triggered	VBN	trigger
by	IN	by
FFP	NNP	FFP
transfusion	NN	transfusion
may	MD	may
be	VB	be
exacerbated	VBN	exacerbate
when	WRB	when
patients	NNS	patient
receive	VBP	receive
additional	JJ	additional
intraoperative	JJ	intraoperative
FFP	NNP	FFP
.	.	.
</s>
</p>
<p>
<s type="decl">
Red	JJ	Red
cell	NN	cell
transfusion	NN	transfusion
is	VBZ	be
also	RB	also
a	DT	a
well-known	JJ	well-known
risk	NN	risk
factor	NN	factor
of	IN	of
AKI	NNP	AKI
after	IN	after
liver	NN	liver
transplantation	NN	transplantation
.	.	.
</s>
<s type="decl">
The	DT	the
negative	JJ	negative
effect	NN	effect
of	IN	of
pRBC	NN	pRBC
transfusion	NN	transfusion
is	VBZ	be
multifaceted	JJ	multifaceted
and	CC	and
includes	VBZ	include
a	DT	a
systemic	JJ	systemic
inflammatory	JJ	inflammatory
response	NN	response
,	,	,
which	WDT	which
contributes	VBZ	contribute
to	IN	to
the	DT	the
development	NN	development
of	IN	of
AKI	NNP	AKI
after	IN	after
surgery	NN	surgery
.	.	.
</s>
<s type="decl">
A	DT	a
large	JJ	large
amount	NN	amount
of	IN	of
transfusion	NN	transfusion
reflects	VBZ	reflect
excessive	JJ	excessive
surgical	JJ	surgical
bleeding	NN	bleeding
,	,	,
which	WDT	which
leads	VBZ	lead
to	IN	to
renal	JJ	renal
hypoperfusion	NN	hypoperfusion
and	CC	and
ischemia	NN	ischemia
,	,	,
resulting	VBG	result
in	IN	in
poor	JJ	poor
oxygen	NN	oxygen
delivery	NN	delivery
.	.	.
</s>
<s type="decl">
There	EX	there
was	VBD	be
a	DT	a
dose	NN	dose
â€“	:	-
response	NN	response
relationship	NN	relationship
between	IN	between
the	DT	the
amount	NN	amount
of	IN	of
pRBC	NN	pRBC
and	CC	and
FFP	NNP	FFP
transfusion	NN	transfusion
and	CC	and
the	DT	the
risk	NN	risk
of	IN	of
AKI	NNP	AKI
in	IN	in
our	PRP$	our
study	NN	study
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
it	PRP	it
is	VBZ	be
not	RB	not
clear	JJ	clear
why	WRB	why
the	DT	the
patients	NNS	patient
undergoing	VBG	undergo
ABO-i	NNP	ABO-i
LT	NNP	LT
were	VBD	be
more	RBR	more
susceptible	JJ	susceptible
to	IN	to
the	DT	the
deleterious	JJ	deleterious
effects	NNS	effect
of	IN	of
pRBC	NN	pRBC
transfusion	NN	transfusion
.	.	.
</s>
<s type="decl">
Possible	JJ	Possible
mechanisms	NNS	mechanism
include	VBP	include
that	IN	that
the	DT	the
adverse	JJ	adverse
effect	NN	effect
of	IN	of
pRBC	NN	pRBC
transfusion	NN	transfusion
may	MD	may
be	VB	be
aggravated	VBN	aggravate
by	IN	by
a	DT	a
high	JJ	high
isoagglutinin	NN	isoagglutinin
titer	NN	titer
.	.	.
</s>
<s type="sub">
Although	IN	although
we	PRP	we
accounted	VBD	account
for	IN	for
confounding	VBG	confound
factors	NNS	factor
through	IN	through
propensity-score-matching	NN	propensity-score-matching
and	CC	and
multivariable	JJ	multivariable
analysis	NN	analysis
,	,	,
we	PRP	we
could	MD	could
not	RB	not
adjust	VB	adjust
the	DT	the
isoagglutinin	NN	isoagglutinin
titer	NN	titer
due	JJ	due
to	IN	to
a	DT	a
lack	NN	lack
of	IN	of
data	NNS	datum
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
,	,	,
red	JJ	red
cell	NN	cell
transfusion	NN	transfusion
is	VBZ	be
closely	RB	closely
related	JJ	related
to	IN	to
FFP	NNP	FFP
transfusion	NN	transfusion
.	.	.
</s>
<s type="decl">
Cumulative	JJ	cumulative
FFP	NNP	FFP
transfusion	NN	transfusion
after	IN	after
preoperative	JJ	preoperative
plasma	NN	plasma
exchange	NN	exchange
could	MD	could
be	VB	be
the	DT	the
leading	VBG	lead
cause	NN	cause
,	,	,
and	CC	and
pRBC	NN	pRBC
transfusion	NN	transfusion
could	MD	could
be	VB	be
a	DT	a
simple	JJ	simple
association	NN	association
.	.	.
</s>
</p>
<p>
<s type="sub">
To	TO	to
reduce	VB	reduce
the	DT	the
transfusion	NN	transfusion
amount	NN	amount
in	IN	in
ABO-i	NNP	ABO-i
LT	NNP	LT
,	,	,
we	PRP	we
could	MD	could
adopt	VB	adopt
a	DT	a
restrictive	JJ	restrictive
transfusion	NN	transfusion
policy	NN	policy
by	IN	by
decreasing	VBG	decrease
the	DT	the
transfusion	NN	transfusion
threshold	NN	threshold
.	.	.
</s>
<s type="decl">
Although	IN	although
there	EX	there
is	VBZ	be
no	DT	no
established	VBN	establish
consensus	NN	consensus
regarding	VBG	regard
intraoperative	JJ	intraoperative
transfusion	NN	transfusion
,	,	,
the	DT	the
pRBC	NN	pRBC
transfusion	NN	transfusion
threshold	NN	threshold
in	IN	in
our	PRP$	our
institution	NN	institution
during	IN	during
liver	NN	liver
transplantation	NN	transplantation
was	VBD	be
around	RB	around
20	CD	20
%	NN	%
in	IN	in
hematocrit	NN	hematocrit
.	.	.
</s>
<s type="decl">
This	DT	this
threshold	NN	threshold
could	MD	could
be	VB	be
lowered	VBN	lower
further	RBR	far
depending	VBG	depend
on	IN	on
the	DT	the
baseline	NN	baseline
status	NN	status
of	IN	of
recipients	NNS	recipient
or	CC	or
the	DT	the
mixed	VBN	mix
venous	JJ	venous
oxygen	NN	oxygen
concentrations	NNS	concentration
.	.	.
</s>
<s type="sub">
Red	JJ	Red
cell	NN	cell
transfusion	NN	transfusion
during	IN	during
surgery	NN	surgery
could	MD	could
possibly	RB	possibly
be	VB	be
reduced	VBN	reduce
by	IN	by
optimizing	VBG	optimize
baseline	JJ	baseline
hematocrit	NN	hematocrit
before	IN	before
surgery	NN	surgery
through	IN	through
the	DT	the
administration	NN	administration
of	IN	of
erythropoietin	NN	erythropoietin
.	.	.
</s>
<s type="decl">
A	DT	a
previous	JJ	previous
randomized	JJ	randomized
trial	NN	trial
reported	VBD	report
that	IN	that
a	DT	a
preoperative	JJ	preoperative
single	JJ	single
intravenous	JJ	intravenous
dose	NN	dose
of	IN	of
erythropoietin	NN	erythropoietin
could	MD	could
reduce	VB	reduce
the	DT	the
transfusion	NN	transfusion
amount	NN	amount
during	IN	during
cardiac	JJ	cardiac
surgery	NN	surgery
,	,	,
thereby	RB	thereby
reducing	VBG	reduce
the	DT	the
incidence	NN	incidence
of	IN	of
postoperative	JJ	postoperative
AKI	NNP	AKI
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
,	,	,
to	TO	to
reduce	VB	reduce
transfusion	NN	transfusion
requirements	NNS	requirement
,	,	,
the	DT	the
intraoperative	JJ	intraoperative
use	NN	use
of	IN	of
vasopressin	NN	vasopressin
was	VBD	be
reported	VBN	report
to	TO	to
reduce	VB	reduce
surgical	JJ	surgical
bleeding	NN	bleeding
through	IN	through
selective	JJ	selective
splanchnic	JJ	splanchnic
vasoconstriction	NN	vasoconstriction
and	CC	and
by	IN	by
reducing	VBG	reduce
portal	JJ	portal
blood	NN	blood
flow	NN	flow
.	.	.
</s>
</p>
<p>
<s type="decl">
The	DT	the
incidence	NN	incidence
of	IN	of
AKI	NNP	AKI
in	IN	in
our	PRP$	our
study	NN	study
was	VBD	be
within	IN	within
the	DT	the
range	NN	range
reported	VBN	report
in	IN	in
previous	JJ	previous
literature	NN	literature
.	.	.
</s>
<s type="decl">
The	DT	the
incidence	NN	incidence
of	IN	of
AKI	NNP	AKI
in	IN	in
ABO-i	NNP	ABO-i
LT	NNP	LT
was	VBD	be
also	RB	also
similar	JJ	similar
to	IN	to
a	DT	a
previous	JJ	previous
study	NN	study
.	.	.
</s>
<s type="decl">
The	DT	the
risk	NN	risk
factors	NNS	factor
of	IN	of
AKI	NNP	AKI
other	JJ	other
than	IN	than
ABO-i	NNP	ABO-i
LT	NNP	LT
were	VBD	be
mostly	RB	mostly
consistent	JJ	consistent
with	IN	with
those	DT	this
of	IN	of
the	DT	the
previous	JJ	previous
literature	NN	literature
.	.	.
</s>
<s type="decl">
The	DT	the
preoperative	JJ	preoperative
hemoglobin	NN	hemoglobin
level	NN	level
was	VBD	be
independently	RB	independently
associated	VBN	associate
with	IN	with
post-transplant	JJ	post-transplant
AKI	NNP	AKI
.	.	.
</s>
<s type="decl">
The	DT	the
MELD	NNP	MELD
score	NN	score
has	VBZ	have
been	VBN	be
consistently	RB	consistently
reported	VBN	report
to	TO	to
be	VB	be
a	DT	a
predictor	NN	predictor
of	IN	of
AKI	NNP	AKI
.	.	.
</s>
<s type="decl">
Ischemic	JJ	Ischemic
time	NN	time
was	VBD	be
not	RB	not
identified	VBN	identify
as	IN	as
an	DT	a
independent	JJ	independent
predictor	NN	predictor
of	IN	of
AKI	NNP	AKI
in	IN	in
our	PRP$	our
analysis	NN	analysis
,	,	,
which	WDT	which
could	MD	could
have	VB	have
been	VBN	be
due	JJ	due
to	IN	to
the	DT	the
relatively	RB	relatively
short	JJ	short
ischemic	JJ	ischemic
time	NN	time
of	IN	of
LDLT	NNP	LDLT
.	.	.
</s>
</p>
</text>